BlackRock
ATXI

BlackRock’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

BlackRock’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17
Closed -$202 – 5415
2023
Q4 		$202 Sell
17
-8
-32% -$187 ﹤0.01% 5318
2023
Q3 		$1.32K Sell
25
-1
-4% -$71 ﹤0.01% 5316
2023
Q2 		$2.27K Hold
26
– – ﹤0.01% 5366
2023
Q1 		$2.26K Hold
26
– – ﹤0.01% 5437
2022
Q4 		$2.25K Hold
26
– – ﹤0.01% 5593
2022
Q3 		$20K Hold
26
– – ﹤0.01% 5520
2022
Q2 		$7K Sell
26
-23
-47% -$8.86K ﹤0.01% 5657
2022
Q1 		$27K Buy
49
+6
+14% +$4.49K ﹤0.01% 5524
2021
Q4 		$44K Hold
43
– – ﹤0.01% 5423
2021
Q3 		$72K Hold
43
– – ﹤0.01% 5223
2021
Q2 		$120K Sell
43
-280
-87% -$1.38M ﹤0.01% 5000
2021
Q1 		$2.2M Buy
323
+2
+0.6% +$13.7K ﹤0.01% 4259
2020
Q4 		$2.15M Buy
321
+16
+5% +$83.9K ﹤0.01% 4016
2020
Q3 		$3.71M Buy
305
+21
+7% +$255K ﹤0.01% 3701
2020
Q2 		$3.44M Buy
284
+242
+576% +$2.73M ﹤0.01% 3663
2020
Q1 		$420K Buy
42
+3
+8% +$30.1K ﹤0.01% 4088
2019
Q4 		$418K Buy
39
+4
+11% +$28K ﹤0.01% 4190
2019
Q3 		$231K Hold
35
– – ﹤0.01% 4312
2019
Q2 		$251K Buy
35
+20
+133% +$116K ﹤0.01% 4329
2019
Q1 		$80K Sell
15
-1
-6% -$6.38K ﹤0.01% 4409
2018
Q4 		$98K Hold
16
– – ﹤0.01% 4358
2018
Q3 		$52K Hold
16
– – ﹤0.01% 4541
2018
Q2 		$63K Buy
16
+1
+7% +$4.64K ﹤0.01% 4528
2018
Q1 		$75K Hold
15
– – ﹤0.01% 4384
2017
Q4 		$62K Hold
15
– – ﹤0.01% 4404
2017
Q3 		$91K Buy
+15
New +$110K ﹤0.01% 4380

Other funds holding ATXI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock's ATXI Position: Q1 2024 in Review

BlackRock sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q1 2024, closing a stake of 17 shares — an estimated $202 sold.

BlackRock first reported a position in ATXI in Q3 2017 and held it in 26 quarters. The position peaked at $3.71M in Q3 2020. 13 funds tracked by Wall St. Rank hold ATXI as of Q1 2024.

  • BlackRock reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • BlackRock sold 17 Avenue Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $202.
  • BlackRock first reported a position in Avenue Therapeutics, Inc. Common Stock in Q3 2017 and held it in 26 quarters.
  • BlackRock's Avenue Therapeutics, Inc. Common Stock position peaked at $3.71M in Q3 2020.
  • 13 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.